| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15,367 |
13,903 |
$589K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15,334 |
13,879 |
$588K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
13,709 |
13,072 |
$345K |
| 87512 |
|
6,895 |
6,426 |
$335K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
7,853 |
7,445 |
$313K |
| 87481 |
|
6,911 |
5,944 |
$264K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
8,027 |
7,448 |
$257K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,430 |
2,277 |
$202K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
10,418 |
1,554 |
$168K |
| 87799 |
|
3,057 |
1,691 |
$104K |
| 87653 |
|
2,728 |
2,597 |
$88K |
| G0141 |
Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician |
1,781 |
1,691 |
$32K |
| 88342 |
|
337 |
313 |
$21K |
| 87081 |
|
2,728 |
2,596 |
$21K |
| 87529 |
|
508 |
232 |
$20K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
231 |
226 |
$5K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
601 |
571 |
$3K |
| 88112 |
|
45 |
43 |
$3K |
| 88307 |
|
17 |
17 |
$2K |
| 87660 |
|
14 |
13 |
$350.19 |
| 87510 |
|
14 |
13 |
$336.55 |
| 87480 |
|
14 |
13 |
$335.55 |
| 87625 |
|
47 |
43 |
$134.29 |